Mingyuan Medicare Development Acquires Shanghai Kang Pei Bio-Medical
This article was originally published in PharmAsia News
Executive Summary
Following an agreement in October, Mingyuan Medicare Development has completed the acquisition of 75 percent stake in Shanghai Kang Pei Bio-Medical with RMB 310 million in cash. Together with three subsidiaries and two joint-venture firms, Kang Pei Bio-Medical focuses on providing medical diagnosis, check-ups and health care evaluation services to China's customers, including Mingyuan Medicare's affiliated companies for the past two years. Kang Pei Bio-Medical has set up 12 health care centers in Shanghai, Tianjin, Chengdu and Taiyuan; these facilities annually service more than 400,000 customers. (Click here for more - Chinese Language)